REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Samsung Biologics Co., Ltd. (South Korea)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: Samsung Biologics Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Samsung Biologics Co.,Ltd is a biopharmaceutical company operating in the pharmaceutical biotechnology farming industry. The company offers mRNA manufacturing, ADC manufacturing, and clinical and commercial biologics manufacturing. Samsung Biologics is focused on the global market.

Headquarters
300 Songdo Bio Way (Daero), Yeonsu-Gu
Incheon; Incheon;

Contact Details: Purchase the Samsung Biologics Co., Ltd. report to view the information.

Website: http://www.samsungbiologics.com

Basic Information
Total Employees:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Registered Capital:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Incorporation Date:
April 22, 2011
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
43.4%
Purchase this report to view the information.
31.5%
Purchase this report to view the information.
0.1%
Purchase this report to view the information.
Subsidiaries
Samsung Biologics America, Inc. (United States)
Company Performance
Financial values in the chart are available after Samsung Biologics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
32.56%▲
Total operating revenue
32.46%▲
Operating profit (EBIT)
47.25%▲
EBITDA
105.22%▲
Net Profit (Loss) for the Period
52.26%▲
Total assets
4.08%▲
Total equity
10.93%▲
Operating Profit Margin (ROS)
3.12%▲
Net Profit Margin
3.06%▲
Return on Equity (ROE)
1.31%▲
Debt to Equity Ratio
-9.16%▼
Quick Ratio
-0.09%▼
Cash Ratio
0.09%▲

Similar companies

Lg Chem Co.,Ltd.
 
Hanwha Corp.
Samsung C&T Corporation
 
S-Oil Co.,Ltd.
Cj Cheiljedang Corporation
 
Samsung Sdi Co.,Ltd.
Hyosung Corporation
 
Basf Company Limited
Lotte Advanced Materials Co.,Ltd.
 
Hyundai Cosmo Petrochemical Co.,Ltd.
Hyosung Chemical Corp
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo